Brown, Pamela
Dawson, Michael J
Article History
Received: 12 September 2016
Revised: 2 November 2016
Accepted: 12 November 2016
First Online: 11 January 2017
Competing interests
: The authors are employees of Cantab Anti-infectives Ltd., which company has a commercial arrangement with Spero Therapeutics Ltd. Compounds under development by both companies are included in this review.
Free to read: This content has been made available to all.